Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

TRI-1144 well tolerated in healthy subjects

Oct. 29, 2008

RN-18 inhibits viral replication by targeting a novel HIV-1 protein

Oct. 28, 2008

CytoDyn files new IND for proof-of-principle study to reconfirm dose range of Cytolin

Oct. 24, 2008

FDA approves Prezista once-daily as part of combination therapy in HIV

Oct. 23, 2008

GeoVax ships DNA and MVA vaccines to HVTN for phase IIa human clinical trial

Oct. 22, 2008

Recent Auspex patent reports novel anti-HIV agents

Oct. 20, 2008

New anti-HIV agents imparted in recent Metastatix patent

Oct. 13, 2008

Merck & Co. to evaluate use of once-daily raltegravir in HIV patients

Oct. 9, 2008

FDA approves Reyataz boosted with ritonavir in HIV

Oct. 3, 2008

Myriad presents top-line results from phase I Vivecon trial

Sep. 18, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...